Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124878502 | 12487850 | 2 | F | 20160912 | 20160622 | 20160923 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-048300 | BRISTOL MYERS SQUIBB | 0.00 | F | Y | 0.00000 | 20160923 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124878502 | 12487850 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Unknown | 30 MG, UNK | 21436 | 30 | MG | ||||||||
| 124878502 | 12487850 | 2 | SS | GABAPENTIN. | GABAPENTIN | 1 | Unknown | 600 MG, TID | U | 0 | 600 | MG | TID | ||||||
| 124878502 | 12487850 | 3 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | 500 MG, BID | U | 0 | 500 | MG | BID | ||||||
| 124878502 | 12487850 | 4 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
| 124878502 | 12487850 | 5 | C | CARBAMAZEPINE. | CARBAMAZEPINE | 1 | Unknown | 200 MG, BID | U | 0 | 200 | MG | BID | ||||||
| 124878502 | 12487850 | 6 | C | HALDOL | HALOPERIDOL | 1 | Unknown | UNK, BID | U | 0 | BID | ||||||||
| 124878502 | 12487850 | 7 | C | NPH /00030513/ | 2 | Unknown | 70 UNIT, BID | U | 0 | 70 | DF | INJECTION | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124878502 | 12487850 | 1 | Product used for unknown indication |
| 124878502 | 12487850 | 2 | Neuropathy peripheral |
| 124878502 | 12487850 | 3 | Product used for unknown indication |
| 124878502 | 12487850 | 4 | Product used for unknown indication |
| 124878502 | 12487850 | 5 | Product used for unknown indication |
| 124878502 | 12487850 | 6 | Product used for unknown indication |
| 124878502 | 12487850 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124878502 | 12487850 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124878502 | 12487850 | Cardiac failure | |
| 124878502 | 12487850 | Cataract | |
| 124878502 | 12487850 | Cough | |
| 124878502 | 12487850 | Discomfort | |
| 124878502 | 12487850 | Drug ineffective | |
| 124878502 | 12487850 | Lung disorder | |
| 124878502 | 12487850 | Neuropathy peripheral | |
| 124878502 | 12487850 | Off label use | |
| 124878502 | 12487850 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |